Skip to main content
OpenTrials
Completed

NCT Number: NCT01779011

Monitoring and Treatment of Extremity Trauma for Mass Casualties in Difficult Contexts

The prospective cohort study, SuTra2, assesses the functional and socio-economic status of patients who were operated on for a severe limb injury resulting in amputation or limb preservation 1 and 2 years after the 2010 Haiti earthquake.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

ALIMA

Port-au-Prince, Haiti

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients, with limb injuries due to the earthquake,
  • Who underwent limb surgery, which ended up in limb amputation or limb conservation.

Exclusion criteria

  • Limb injury not related to the earthquake
  • No surgery for the limb injury

Treatment and study plan

Primary outcomes

  1. Patient Satisfaction with Musculoskeletal functional recovery

    Time frame: 2 years

Secondary outcomes

  1. Employment status

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Alliance for International Medical Action

Other

Collaborators

  • Lille Economie Management UMR CNRS 8157
  • National Research Agency, France

Registry information

Official study title

Suivi et Traitement du Traumatisme Des Membres en Cas d'Afflux Massif de blessés Dans Les Contextes Difficiles

Acronym: SuTra²

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Jan 29, 2013
Registry last updated
Jan 29, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.